|
|
|
AstraZeneca
keen to invest in Indian biotech, pharma |
| |
AstraZeneca Pharma India, the
Indian subsidiary of $15 billion AstraZeneca AB of Sweden is
interested to invest in smaller pharma and biotech companies
as a venture capitalist, which offer some security on their
intellectual property. |
|
|
CESC
to hike borrowing limit to Rs 3,800 crore |
| |
The cash-strapped RPG Group
public utility concern CESC is planning to hike its borrowing
limit to Rs 3,800 crore. In order to meet a part of the company’s
working capital requirements and for retirement of high cost
borrowings of the company, ICICI has sanctioned a term loan
amounting to Rs 660 crore. |
|
|
|
| |
|
|
Centre
mulls amending Atomic Energy Act for private sector entry |
| |
The Centre is working on certain
amendments to the Atomic Energy Act in order to enable the private
sector to play a role in the area of nuclear power technology. |
|
|
Daikin
Shriram plans to notch up Rs 100-cr sales this fiscal |
| |
Daikin Shriram Aircondtioning
Pvt Ltd is looking at a turnover of Rs 100 crore in this financial
year. The company has set itself a target of achieving critical
mass with a turnover of Rs 200 crore for setting up a dedicated
manufacturing base in the country. |
|
